Literature DB >> 3972418

Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts.

G H Boers, B Fowler, A G Smals, F J Trijbels, A I Leermakers, W J Kleijer, P W Kloppenborg.   

Abstract

Previous data on tentative identification of the carrier state for homocystinuria due to cystathionine synthase deficiency using methionine loading or measurement of cystathionine synthase activity in tissue extracts are conflicting. We studied the results of standardized oral methionine loading in 20 obligate heterozygotes and compared them with those of determination of cystathionine synthase activity in cultured fibroblasts. Special attention was devoted to our recently reported observation on the small but striking differences in methionine metabolism between healthy pre- and postmenopausal women and men. Fasting and after load peak levels of methionine in serum did not discriminate the carriers from the control subjects. The mean fasting level of total homocysteine was only significantly higher in the group of premenopausal heterozygotes than in the corresponding control group. Nevertheless, the individual values overlapped with the normal range in 4 of 12 premenopausal heterozygotes. After loading peak levels of total homocysteine in 18 out of the 20 obligate heterozygotes exceeded the upper limit of the ranges in the three control groups. Thus, this parameter discriminated 90% of the obligate carriers. Measurement of cystathionine synthase activity in cultured fibroblasts from a skin biopsy identified the obligate heterozygotes to a similar degree (85%). No significant correlation between the measurements of cystathionine synthase activity and the after load peak levels of total homocysteine in the individual heterozygotes was established. Combination of both methionine loading and determination of cystathionine synthase activity in cultured fibroblasts identified all of these carriers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972418     DOI: 10.1007/bf00293290

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  HOMOCYSTINURIA: METABOLIC STUDIES ON 3 PATIENTS.

Authors:  D P BRENTON; D C CUSWORTH; G E GAULL
Journal:  J Pediatr       Date:  1965-07       Impact factor: 4.406

2.  Homocystinuria: studies in tissue culture.

Authors:  B W Uhlendorf; E B Conerly; S H Mudd
Journal:  Pediatr Res       Date:  1973-07       Impact factor: 3.756

3.  Homocystinuria: a report in two siblings.

Authors:  C Kennedy; V E Shih; L P Rowland
Journal:  Pediatrics       Date:  1965-11       Impact factor: 7.124

4.  Homocystinuria versus Marfan's syndrome: the therapeutic relevance of the differential diagnosis.

Authors:  G H Boers; T W Polder; J R Cruysberg; H C Schoonderwaldt; J J Peetoom; T W Van Ruyven; A G Smals; P W Kloppenborg
Journal:  Neth J Med       Date:  1984       Impact factor: 1.422

5.  Homocystinuria: the effect of pyridoxine supplementation on cultured skin fibroblasts.

Authors:  A H Bittles; N A Carson
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

6.  Homocystinuria. A recently discovered cause of mental defect and cerebrovascular thrombosis.

Authors:  H G Dunn; T L Perry; C L Dolman
Journal:  Neurology       Date:  1966-04       Impact factor: 9.910

7.  Treatment of homocystinuria.

Authors:  H P Chase; S I Goodman; D O'Brien
Journal:  Arch Dis Child       Date:  1967-10       Impact factor: 3.791

8.  HOMOCYSTINURIA DUE TO CYSTATHIONINE SYNTHETASE DEFICIENCY: THE MODE OF INHERITANCE.

Authors:  J D FINKELSTEIN; S H MUDD; F IRREVERRE; L LASTER
Journal:  Science       Date:  1964-11-06       Impact factor: 47.728

9.  Homocystinuria due to cystathionine synthase deficiency: the metabolism of L-methionine.

Authors:  L Laster; S H Mudd; J D Finkelstein; F Irreverre
Journal:  J Clin Invest       Date:  1965-10       Impact factor: 14.808

10.  Homocystinuria due to cystathionine synthase deficiency.

Authors: 
Journal:  Ann Intern Med       Date:  1965-12       Impact factor: 25.391

View more
  14 in total

1.  The effect of a subnormal vitamin B-6 status on homocysteine metabolism.

Authors:  J B Ubbink; A van der Merwe; R Delport; R H Allen; S P Stabler; R Riezler; W J Vermaak
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Delay in diagnosis of homocystinuria: retrospective study of consecutive patients.

Authors:  J R Cruysberg; G H Boers; J M Trijbels; A F Deutman
Journal:  BMJ       Date:  1996-10-26

Review 3.  Disorders of homocysteine metabolism.

Authors:  B Fowler
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 4.  Hyperhomocysteinaemia; with reference to its neuroradiological aspects.

Authors:  M van den Berg; M S van der Knaap; G H Boers; C D Stehouwer; J A Rauwerda; J Valk
Journal:  Neuroradiology       Date:  1995-07       Impact factor: 2.804

5.  The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment.

Authors:  L A Kluijtmans; G H Boers; J P Kraus; L P van den Heuvel; J R Cruysberg; F J Trijbels; H J Blom
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

6.  Homocysteine, factor VII and antithrombin III in subjects with different gene dosage for cystathionine beta-synthase.

Authors:  L Brattström; B Israelsson; L Tengborn; B Hultberg
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

7.  Homocysteine response to methionine challenge in four obligate heterozygotes for homocystinuria and relationship with cystathionine beta-synthase mutations.

Authors:  M P Sperandeo; M Candito; G Sebastio; M O Rolland; C Turc-Carel; H Giudicelli; P Dellamonica; G Andria
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

8.  Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.

Authors:  L A Kluijtmans; L P van den Heuvel; G H Boers; P Frosst; E M Stevens; B A van Oost; M den Heijer; F J Trijbels; R Rozen; H J Blom
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

9.  Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia.

Authors:  A M Engbersen; D G Franken; G H Boers; E M Stevens; F J Trijbels; H J Blom
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.

Authors:  Y I Lolin; J E Sanderson; S K Cheng; C F Chan; C P Pang; K S Woo; J R Masarei
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.